4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-26-144080
Chief Medical Officer sold 6,700 shares at $24.58 ($164,686)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Simon Amy Chief Medical Officer | 2026-04-01 | Sale 10b5-1 | −6,700 | $24.58 | $164,686 | 102,735 | D: show line 1 in the form |
| Open-market sales · 6,700 sh · avg $24.58 · $164,686 | |||||||
Loading xslF345X06/ownership.xml…